Similar Articles
531 Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
532 Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
533 Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma
534 Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
535 Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
536 Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma
537 Radiomics in hepatocellular carcinoma: A state-of-the-art review
538 Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
539 Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis
540 Hepatocellular carcinoma biomarkers, an imminent need
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA